Akebia Therapeutics (AKBA) Gross Profit Growth (3y) (2021 - 2026)
Akebia Therapeutics (AKBA) Gross Profit Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 7.62% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 4.71% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 12.55% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 76.85% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 24.80% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 0.95% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -35.83% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 44.16% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 37.26% |
| 10 | Akebia Therapeutics | 235.00 Mn | 72.40 Mn | 41.25 Mn | 12.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.69% |
| Dec 31, 2025 | -12.89% |
| Sep 30, 2025 | 36.44% |
| Jun 30, 2025 | 28.60% |
| Mar 31, 2025 | 39.61% |
| Dec 31, 2024 | 82.35% |
| Sep 30, 2024 | -10.83% |
| Jun 30, 2024 | 41.30% |
| Mar 31, 2024 | 3.96% |
| Dec 31, 2023 | 42.81% |
| Sep 30, 2023 | 77.34% |
| Jun 30, 2023 | 36.97% |
| Mar 31, 2023 | -25.55% |
| Dec 31, 2022 | 110.97% |
| Sep 30, 2022 | 39.04% |
| Jun 30, 2022 | -10.13% |
| Mar 31, 2022 | 61.88% |
| Dec 31, 2021 | -457.60% |